We are live on ! Find out more
QSI icon

Quantum-Si

0.9090 USD
-0.1610
15.05%
At close Updated Nov 20, 4:00 PM EST
Pre-market
After hours
0.9299
+0.0209
2.3%
1 day
-15.05%
5 days
-17.36%
1 month
-21.64%
3 months
16.54%
6 months
3.8%
Year to date
-21.64%
1 year
-26.69%
5 years
-86.65%
10 years
-90.8%
 

About: Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.

Employees: 145

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 6.3%
Neutral 75%
Negative 18.8%
Neutral
GlobeNewsWire
3 days ago
Quantum-Si Achieves Historic Milestone in Protein Sequencing with Single-Molecule Detection of All 20 Amino Acids on Proteus™
Achievement establishes complete amino acid detection as a new benchmark for single-molecule protein sequencing Capability is expected to lay the foundation for reference-free protein identification and expanded analysis of proteoforms BRANFORD, Conn., Nov. 18, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule protein sequencing, today announced that it has demonstrated detection of all 20 naturally occurring amino acids in its Proteus development program, achieving its year-end 2026 goal ahead of schedule.
Quantum-Si Achieves Historic Milestone in Protein Sequencing with Single-Molecule Detection of All 20 Amino Acids on Proteus™
Neutral
GlobeNewsWire
7 days ago
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that the Compensation Committee of Quantum-Si's Board of Directors has granted 495,335 restricted stock units (“RSUs”) to new employees under the Company's previously adopted Quantum-Si Incorporated 2023 Inducement Equity Incentive Plan, as amended (the “2023 Inducement Plan”).
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Positive
MarketBeat
15 days ago
Quantum-Si Q3 Earnings Call Highlights
Quantum-Si NASDAQ: QSI reported lower third-quarter revenue and narrowed its net loss as it prepared for the planned second-quarter 2027 commercial launch of its Proteus protein sequencing platform.
Quantum-Si Q3 Earnings Call Highlights
Neutral
Seeking Alpha
15 days ago
Quantum-Si incorporated (QSI) Q3 2026 Earnings Call Transcript
Quantum-Si incorporated (QSI) Q3 2026 Earnings Call Transcript
Quantum-Si incorporated (QSI) Q3 2026 Earnings Call Transcript
Negative
Zacks Investment Research
15 days ago
Quantum-Si Incorporated (QSI) Reports Q3 Loss, Misses Revenue Estimates
Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.17 per share a year ago.
Quantum-Si Incorporated (QSI) Reports Q3 Loss, Misses Revenue Estimates
Neutral
GlobeNewsWire
15 days ago
Quantum-Si Reports Third Quarter 2026 Financial Results and Provides Business Update
BRANFORD, Conn., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule protein sequencing, today announced financial results for the third quarter ended September 30, 2026.
Quantum-Si Reports Third Quarter 2026 Financial Results and Provides Business Update
Neutral
GlobeNewsWire
1 month ago
Quantum-Si to Provide a Business Update and Report Third Quarter 2026 Financial Results on November 5, 2026
BRANFORD, Conn., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will provide a business update and report financial results for the third quarter 2026 on Thursday, November 5, 2026.
Quantum-Si to Provide a Business Update and Report Third Quarter 2026 Financial Results on November 5, 2026
Neutral
GlobeNewsWire
1 month ago
Quantum-Si Regains Compliance with Nasdaq Minimum Bid Price Requirement
BRANFORD, Conn., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI,” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that it has received written notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Global Market under Listing Rule 5450(a)(1).
Quantum-Si Regains Compliance with Nasdaq Minimum Bid Price Requirement
Neutral
Seeking Alpha
1 month ago
Leading Indicators For The October Breakout Cycle
Q4 historically delivers outsized S&P 500 returns, especially following midterm election years, supporting the 'October breakout cycle' thesis. Since 2000, the gains in the fourth quarter have averaged more than half of the S&P 500's annual returns with more positive years than all the other quarters. Small cap healthcare/biotech, technology, and consumer cyclicals—like PRME, CRNC, and FOSL—are highlighted as early breakout candidates with strong institutional interest and analyst targets.
Leading Indicators For The October Breakout Cycle
Negative
InvestorPlace
1 month ago
Beyond Elon Musk's Neuralink: Two Public Stocks With a Stake in the Brain Race
Elon Musk's Neuralink is giving us a glimpse of a future in which the human brain can communicate directly with computers. For investors, there's just one problem: You can't buy Neuralink stock.
Beyond Elon Musk's Neuralink: Two Public Stocks With a Stake in the Brain Race
Price charts implemented using Lightweight Charts™